Companies · Biotechnology

One World Lab, Inc.

SAN DIEGO · Biotechnology

Diligence memoA one-page analyst read on One World Lab, Inc. — recommendation, valuation, rhythm, risks.
$981K
Total raised · real
1
Rounds
Latest step-up
Top 84%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

One World Lab, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 3.42× the median modeled value of Pre-Seed Biotechnology companies in 2013–2015 (131 peers) — value vs value, same stage and era.
Dormant
  • Last raise 11.2 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

One World Lab, Inc. is one of 4291 Biotechnology companies tracked from SAN DIEGO. By capital raised it ranks in the long tail (ahead of 17% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$25M$50M$75M$100MPre-Seed · 2015-04-07 Raised $981K (real) Modeled valuation $54M (est)$981K$54MPre-Seed2015

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$981K · 2015

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$54.2M
Base estimate est.
$523K
Conservative case
$614.4M
Upside case
$5.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
24%
Survival probability
10% low · 44% high
1.86×/yr
Annual markup
2.52×/yr upside case
6.0 yr
Elapsed time used
11.2 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
11.2 yr
On record since
2015
First round
1
Rounds on file
How it compares to the market

Benchmarked against 4291 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.1× of median
This company$981K
Sector median$7.2M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 2.4× above median
This company$981K
Sector median$412K
Modeled value — vs sector median (estimate, all stages) 0.8× of median
This company$54.2M
Sector median$64.2M

Raised more than 17% of sector peers (real $). Modeled value above 47% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #5 of 131.

This companyCohort peer
$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Truminim, LLC · Pre-Seed Raised $1.0M · modeled $55.2M (est)Direct Spinal Therapeutics, Inc. · Pre-Seed Raised $1.0M · modeled $55.2M (est)Imanis Life Sciences, LLC · Pre-Seed Raised $1.0M · modeled $55.2M (est)Universal Biosensors Inc · Pre-Seed Raised $985K · modeled $54.4M (est)Micropharma Ltd · Pre-Seed Raised $851K · modeled $47.0M (est)ConverGene LLC · Pre-Seed Raised $850K · modeled $46.9M (est)CVUS Ventures, LP · Pre-Seed Raised $850K · modeled $46.9M (est)Symbiotic Health, Inc. · Pre-Seed Raised $850K · modeled $46.9M (est)EternoGen Aesthetics, LLC · Pre-Seed Raised $939K · modeled $46.3M (est)Genomics USA, Inc. · Pre-Seed Raised $837K · modeled $46.2M (est)Immunetics, Inc. · Pre-Seed Raised $1.5M · modeled $46.1M (est)One World Lab, Inc. (this company) Raised $981K · modeled $54.2M (est)One World Lab, Inc.
CompanyStageRaised · realValue · estvs peer med.
Truminim, LLCPre-Seed$1.0M$55.2M3.48×
Direct Spinal Therapeutics, Inc.Pre-Seed$1.0M$55.2M3.48×
Imanis Life Sciences, LLCPre-Seed$1.0M$55.2M3.48×
Universal Biosensors IncPre-Seed$985K$54.4M3.43×
One World Lab, Inc. this companyPre-Seed$981K$54.2M3.42×
Micropharma LtdPre-Seed$851K$47.0M2.96×
ConverGene LLCPre-Seed$850K$46.9M2.96×
CVUS Ventures, LPPre-Seed$850K$46.9M2.96×
Symbiotic Health, Inc.Pre-Seed$850K$46.9M2.96×
EternoGen Aesthetics, LLCPre-Seed$939K$46.3M2.92×
Genomics USA, Inc.Pre-Seed$837K$46.2M2.92×
Immunetics, Inc.Pre-Seed$1.5M$46.1M2.91×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$981K2015-04-07$5.5M$54.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$981K2015-04-07
    • First recorded raise — entered as Pre-Seed.
Intelligence
Modeled next raise
$1.6M
Modeled next size est.range $1.0M$2.5M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Kenneth Anderson4 other2015-04
Jonathan Harvey2015-04
Michael Simson2015-04
Registry & provenance

One World Lab, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1626244
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Universal Biosensors IncBiotechnologyPre-Seed$985K$54.4Msame sector · same stage
micro invasive technology, incBiotechnologyPre-Seed$987K$54.5Msame sector · same stage
Pylum Biosciences, Inc.BiotechnologyPre-Seed$990K$54.7Msame sector · same stage
RNAissance AG LLCBiotechnologyPre-Seed$990K$54.7Msame sector · same stage
LightStat, LLCBiotechnologyPre-Seed$970K$53.6Msame sector · same stage
Zeta Biolongevity, Inc.BiotechnologyPre-Seed$995K$54.9Msame sector · same stage
Cyto Wave Technologies Inc.BiotechnologyPre-Seed$965K$53.3Msame sector · same stage
Curis IncBiotechnologyPre-Seed$964K$53.2Msame sector · same stage
Frequently asked
How much funding has One World Lab, Inc. raised?
One World Lab, Inc. has raised approximately $981K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is One World Lab, Inc.'s estimated valuation?
Provath's modeled valuation for One World Lab, Inc. is approximately $54.2M (modeled range $523K–$614.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is One World Lab, Inc. at?
One World Lab, Inc.'s latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Apr 07.
What does One World Lab, Inc. do and where is it based?
One World Lab, Inc. operates in the Biotechnology sector, based in SAN DIEGO.
Explore related

See where One World Lab, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at One World Lab, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.